Nephrocare Health Services Ltd

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Renal One Dialysis Corp. for the acquisition of assets related to a dialysis center in Plaridel, Bulacan, Philippines, for a total consideration of PhP 67,200,000, equivalent to approximately INR 10.25 crores.

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement with Assumption Dialysis Center on August 17, 2026, to acquire assets of a dialysis center in the Philippines for a total consideration of PhP 75,000,000.

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement dated August 12, 2026, with Juan Nephro Dialysis Center to acquire assets of a dialysis center in Davao City, Philippines, for a consideration of PhP 71,800,000.

Nephrocare Health Services Limited clarified that NEPHROPLUS HEALTH SERVICES KAZAKHSTAN Limited Liability Partnership (“NPHSK LLP”), incorporated in the Republic of Kazakhstan on May 26, 2026, is a step-down subsidiary, not a wholly-owned subsidiary, as previously disclosed; Nephrocare Health Services International Pte. Ltd. (“NHSI”), Singapore, a wholly-owned subsidiary of Nephrocare Health Services Limited, holds 99% of NPHSK LLP’s charter capital, with the remaining 1% held by another participant, and the charter capital totals KZT 5,000,000, approximately USD 10,500.

Nephrocare Health Services Ltd share price ticked higher by 0.28% to Rs 696.15 after the company's net profit inched up 5.27% to Rs 31.97 crore, while revenue from operations slightly gained 6.07% to Rs 281.75 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72255.77 crore, improving 10.15%. It has improved by 2.19% over last one week and surged by 17.19% in last one month while the market capitalization of Nephrocare Health Services Ltd has remained flat Profit before tax (PBT) of Nephrocare Health Services Ltd stood at Rs 41.03 crore in Q2 FY26, rallying 43.86% year-on-year, and surging by 23.51% quarter-on-quarter. EBITDA came in at Rs 56 crore, expanding by 37.64% YoY and jumping 33.70% sequentially. Total expenses grew marginally by 1.99% to Rs 242.41 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 62.44 crore, inching up 4.71% YoY, while employee benefits expense was at Rs 47.83 crore, easing 4.14% YoY. For the TTM ended FY26, revenue from operations jumped by 32.16% to Rs 998.85 crore, while net profit registered a growth of 14.52% to Rs 76.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 16974% to Rs 202.46 crore, and PBT rose 11.47% to Rs 97.47 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 232.58 crore in FY26, as against Rs 135.35 crore in FY25. Nephrocare Health Services Ltd surged by 47.61% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.56% during the same period.

Nephrocare Health Services Limited, formerly Nephrocare Health Services Private Limited, reported consolidated revenue from operations of Rs 2,817.54 crore for the quarter ended June 30, 2026, a rise from Rs 2,277.83 crore in the comparable quarter of 2025. Revenue was generated from India (Rs 1,553.79 crore), the Philippines (Rs 906.29 crore), Uzbekistan (Rs 321.34 crore), and other regions (Rs 36.12 crore). The company, listed on the NSE and BSE since December 17, 2025, has utilized Rs 2,074.83 crore of its net IPO proceeds for capital expenditure and general corporate purposes, with Rs 1,176.70 crore remaining unutilized. Nephrocare has also entered into asset transfer arrangements totaling Rs 709.30 crore, with provisional accounting currently in place, and incorporated a new subsidiary in Kazakhstan. The Chairman and Managing Director oversees financial performance, and results are available on the company's and exchange websites.

Nephrocare Health Services will hold a meeting of the Board of Directors of the Company on 11 August 2026.

Nephrocare Health Services announced that the 17th Annual General Meeting(AGM) of the company will be held on 12 August 2026.

Nephrocare Health Services has allotted 2,18,297 equity shares under ESOP on 14 June 2026. Consequently, the paid up equity share capital has increased to Rs 20,11,18,028, comprising 10,05,59,014 equity shares of face value of Rs 2/- each.

Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services, has entered into an Asset Transfer Agreement (ATA) dated 09 June 2026 with Amica Healthcare System Corporation for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines, for a total consideration of PhP 32,640,000, subject to the terms and conditions set out therein.